Advanced search
Start date

Prevalence of abdominal aortic aneurysm in patients with solid tumors and evaluation of the aneurysm diameter in patients under chemotherapy

Grant number: 12/20317-6
Support type:Scholarships in Brazil - Scientific Initiation
Effective date (Start): February 01, 2013
Effective date (End): January 31, 2014
Field of knowledge:Health Sciences - Medicine - Surgery
Principal researcher:Antonio Eduardo Zerati
Grantee:Marianna Almeida Hollaender
Home Institution: Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira (ICESP). Coordenadoria de Serviços de Saúde (CSS). Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil


There are studies in the literature showing that changes in the endothelial function can be caused by chemotherapy, with reports of individuals who developed aortic dissection during cancer treatment. The influence of chemotherapy on the growth and risk of aneurysm rupture is not defined, particularly in dilatation of the abdominal aorta, which are the most frequent. This relationship can influence early indication of surgical treatment of aortic aneurysms in patients in whom chemotherapy is planned, which explains the relevance of this study. Thus, considering that cancer and aortic aneurysms are diseases that affect patients of similar age, it is important to know the prevalence of abdominal aortic aneurysms in patients with solid tumors and the behavior of these aneurysms in patients under chemotherapy. The objective of this study is to determine the prevalence of abdominal aortic aneurysms in patients undergoing cancer treatment for solid tumors at the Cancer Institute of the State of São Paulo (ICESP) admitted between January to June 2010. The other goal is to verify the evolution of the size of the aneurysm in patients undergoing chemotherapy.(AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list by writing to: